MiMedx Group Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +58.4% | +30.8% | +31.1% | +11.8% | +0.0% | -30.9% | -2.5% | +10.7% | +20.0% | +8.5% | +20.0% | |
| – | +59.5% | +60.4% | +8.7% | +3.3% | +0.0% | +8.1% | +0.8% | +21.9% | +13.1% | +10.0% | +21.5% | |
| – | +58.3% | +27.2% | +34.5% | +12.9% | +0.0% | -35.3% | -3.1% | +8.5% | +21.6% | +8.2% | +19.7% | |
| – | +19.3% | +70.5% | +24.8% | -11.9% | +0.0% | -25.7% | -15.2% | +27.9% | -0.3% | -2.6% | +22.3% | |
| – | +47.4% | +27.5% | +27.0% | +16.9% | +0.0% | -28.3% | +9.6% | +5.3% | -1.0% | +8.9% | +18.3% | |
| – | +45.0% | +34.1% | +25.2% | +36.3% | +0.0% | -22.1% | -17.6% | +11.8% | -1.9% | +0.1% | +22.3% | |
| – | +243.2% | -96.4% | +5,128.8% | -108.5% | – | – | – | – | – | +58.6% | +8.5% | |
| – | +79.2% | +294.2% | -74.3% | -100.0% | – | – | -37.3% | +0.7% | +28.7% | -84.4% | +77.2% | |
| – | +244.3% | -97.8% | +8,173.0% | -107.5% | – | – | – | – | – | +87.0% | +15.7% | |
| – | -721.2% | – | -420.2% | – | +0.0% | -146.1% | – | -16.6% | -17,967.0% | – | +15.6% | |
| – | +373.4% | -59.3% | +440.6% | -146.3% | – | – | – | – | – | -37.1% | +14.5% | |
| – | +193.7% | -67.1% | +489.0% | -94.3% | +488.0% | -313.3% | – | – | – | +61.3% | +26.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.